Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Carlo Avalon"'
Autor:
Sunil Sharma, Varun Badami, Edward Rojas, Rahul Sangani, Kyle Chapman, Carlo Avalon, Austin King, Sijin Wen
Publikováno v:
PLoS ONE, Vol 18, Iss 3 (2023)
Objectives To assess the incidence of barotrauma and its impact on mortality in COVID-19 patients admitted to ICU. Design Single-center retrospective study of consecutive COVID-19 patients admitted to a rural tertiary-care ICU. The primary outcomes w
Externí odkaz:
https://doaj.org/article/c6da7dae59444cdf94c9aeb4d0c5c2c1
Autor:
Juan Carlo Avalon, Jacob Fuqua, Tyler Miller, Seth Deskins, Chelby Wakefield, Austin King, Sonya Inderbitzin-Brooks, Christopher Bianco, Lauren Veltri, Wei Fang, Michael Craig, Abraham Kanate, Kelly Ross, Midhun Malla, Brijesh Patel
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-8 (2021)
Abstract Background Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known
Externí odkaz:
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
Autor:
Tyler Miller, David Hana, Saikrishna Patibandla, Daniel Brito Guzman, Juan Carlo Avalon, Irfan Zeb, Madhavi Kadiyala, Jim Mills, Sudarshan Balla, Cathy Kim, Mark Lisle, Mohammad Kawsara, Bryan Raybuck, Ramesh Daggubati, Partho P. Sengupta, Yasmin S. Hamirani
Publikováno v:
Cardiovascular Revascularization Medicine. 41:35-46
Device-related thrombosis (DRT) is one of the greatest challenges of transcatheter left atrial appendage device occlusion. Due to the invasive nature of transesophageal echocardiography (TEE), cardiac computed tomography angiography (CCTA) is being i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6070323c67102f2a3b997803fcae20f
https://doi.org/10.1016/j.carrev.2022.01.028
https://doi.org/10.1016/j.carrev.2022.01.028
Publikováno v:
Journal of Nuclear Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06ef44a20ecef314c787249698a59402
https://doi.org/10.1007/s12350-023-03309-0
https://doi.org/10.1007/s12350-023-03309-0
Autor:
Juan Carlo Avalon, Jacob Fuqua, Seth Deskins, Tyler Miller, Justin Conte, Daniel Martin, Gary Marano, Naveena Yanamala, James Mills, Christopher Bianco, Brijesh Patel, Karthik Seetharam, Raymond Raylman, Partho P. Sengupta, Yasmin S. Hamirani
Publikováno v:
Journal of Nuclear Cardiology. 30:127-139
Technetium-99 pyrophosphate scintigraphy (99mTc-PYP) provides qualitative and semiquantitative diagnosis of ATTR cardiac amyloidosis (ATTR-CA) using the Perugini scoring system and heart/contralateral heart ratio (H/CL) on planar imaging. Standardize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c182cd89002739c7dce9991862c6321e
https://doi.org/10.1007/s12350-022-02988-5
https://doi.org/10.1007/s12350-022-02988-5
Autor:
Jordan L. Lacoste, Thomas W. Szymanski, Juan Carlo Avalon, Galen Kabulski, Utkarsh Kohli, Nassir Marrouche, Atul Singla, Sudarshan Balla, Arshad Jahangir
Publikováno v:
American Journal of Cardiovascular Drugs. 22:475-496
Atrial fibrillation (AF) is an increasingly common arrhythmia encountered in clinical practice that leads to a substantial increase in utilization of healthcare services and a decrease in the quality of life of patients. The prevalence of AF will con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe8f4c46c21be543eb974e21e220330
https://doi.org/10.1007/s40256-022-00529-6
https://doi.org/10.1007/s40256-022-00529-6
Autor:
Juan Carlo Avalon, Wei Fang, Laura Davisson, Cavan P. O’Kane, Kara Piechowski, Christopher Bianco, Jordan L. Lacoste
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 42:112-118
BACKGROUND Apixaban and rivaroxaban are increasingly used for thromboembolism prophylaxis in patients with nonvalvular atrial fibrillation (NVAF) and commonly in patients with obesity and body mass index (BMI) ≥50 kg/m2 despite limited data. OBJECT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0992ff5e37c7a5eb053eea4621d125ef
https://doi.org/10.1002/phar.2651
https://doi.org/10.1002/phar.2651
Autor:
Michael Craig, Austin King, Sonya Inderbitzin-Brooks, Abraham S. Kanate, Midhun Malla, Seth Deskins, Brijesh Patel, Juan Carlo Avalon, Jacob Fuqua, Christopher Bianco, Tyler Miller, Chelby Wakefield, Wei Fang, Lauren Veltri, Kelly G. Ross
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-8 (2021)
Cardio-oncology
Cardio-oncology
Background Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known that pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5719f963d5c3d7ac40faba74e701d91
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
https://doaj.org/article/dd55526f958e4bdbbb25c6d0cb0df70b
Autor:
Muchi Ditah Chobufo, Yasar Sattar, Karthik Gonuguntla, Ebad Ur Rahman, Anas A. Alharbi, Juan Carlo Avalon, Belal Kaseer, Sudarshan Balla
Publikováno v:
Journal of the American College of Cardiology. 81:525
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87636d5ec01a17464cdaa9b7b899e2f6
https://doi.org/10.1016/s0735-1097(23)00969-5
https://doi.org/10.1016/s0735-1097(23)00969-5
Autor:
Austin King, Seth Deskins, Juan Carlo Avalon, Tyler Miller, Sonya Inderbitzin-Brooks, Abraham S. Kanate, Michael Craig, Chelby Wakefield, Brijesh Patel, Midhun Malla, Jacob Fuqua, Christopher Bianco, Lauren Veltri, Kelly G. Ross, Wei Fang
Background: Ibrutinib is a Bruton’s tyrosine kinase inhibitor used in the treatment of hematological malignancies. The most common cardiotoxicity associated with ibrutinib is atrial arrhythmia (atrial fibrillation and flutter). It is known that pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::948140d7dfdd314f4b06ca31543e716e
https://doi.org/10.21203/rs.3.rs-401031/v1
https://doi.org/10.21203/rs.3.rs-401031/v1
